5 Key Takeaways

• 1

  Two healthy young men developed high-altitude pulmonary hypertension (HAPH) after residing at altitudes above 4,300 meters.

• 2

  Case 1 involved a 21-year-old male who experienced chest pain, shortness of breath, and amaurosis fugax after 4 months at 4,800 meters.

• 3

  Case 2 involved a 20-year-old male who had exertional dyspnea and a brief loss of consciousness after 18 months at 4,300 meters.

• 4

  Echocardiography revealed right atrial and right ventricular enlargement and elevated pulmonary artery pressures in both cases.

• 5

  Treatment for HAPH includes removal from high altitude, with Case 1 showing normalization of pressures, while Case 2 had persistent issues despite oxygen therapy.